(Q35945224)

English

Individualized screening interval for prostate cancer based on prostate-specific antigen level: results of a prospective, randomized, population-based study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Individualized screening interval for prostate cancer based on prostate-specific antigen level: results of a prospective, randomized, population-based study (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

object named as

Johan Stranne

5

0 references

object named as

Hans Lilja

4

0 references

6

object named as

Jonas Hugosson

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

author name string

Gunnar Aus

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Jan-Erik Damber

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Ali Khatami

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

1 September 2005

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

JAMA Internal Medicine

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

165

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

16

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1857-1861

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

The influence of finasteride on the development of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950470

2 October 2017

Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 NG/ML or less

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950470

2 October 2017

Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950470

2 October 2017

Outcome of laterally directed sextant biopsies of the prostate in screened males aged 50--66 years. Implications for sampling order

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950470

2 October 2017

Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng./ml. or less

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950470

2 October 2017

Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950470

2 October 2017

Prospective longitudinal evaluation of men with initial prostate specific antigen levels of 4.0 ng./ml. or less

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950470

2 October 2017

Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1950470

11 July 2018

Screening for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16157829

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale for earlier and less frequent prostate cancer screening

1 reference

https://pubmed.ncbi.nlm.nih.gov/16157829

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor characteristics in screening for prostate cancer with and without rectal examination as an initial screening test at low PSA (0.0-3.9 ng/ml)

1 reference

https://pubmed.ncbi.nlm.nih.gov/16157829

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Possibility of re-screening intervals of more than one year in men with PSA levels of 4.0 ng/ml or less

1 reference

https://pubmed.ncbi.nlm.nih.gov/16157829

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16157829

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16157829

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1001/ARCHINTE.165.16.1857

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35945224&oldid=1958511275"